Jazz Pharmaceuticals JAZZ Return on equity

Return on equity at other companies

AmgenAMGN

91.5%-7.7pp

AlkermesALKS

3.9%-20.1pp

Xenon PharmaceuticalsXENE

-43.6%+8.2pp

Stoke Therapeutics, Inc.STOK

-45.6%-66.1pp

Praxis Precision Medicines, Inc.PRAX

-38.9%-10.3pp

Amneal Pharmaceuticals, Inc.AMRX

-52.8%-12.7pp

FAQ

What is Jazz Pharmaceuticals's return on equity?

Jazz Pharmaceuticals (JAZZ) reported return on equity of -9.1% in Q3 2025.

How has Jazz Pharmaceuticals's return on equity changed year-over-year?

Jazz Pharmaceuticals's return on equity decreased by 175.0% year-over-year, from 12.1% to -9.1%.

What is the long-term trend for Jazz Pharmaceuticals's return on equity?

Over 4 years (2020 to 2024), Jazz Pharmaceuticals's return on equity has grown at a 19.4% compound annual growth rate (CAGR), from 7% to 14.3%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.